Ncoda Funding: How Much Did They Raise & Key Investors

How Much Did Ncoda Raise?
Funding & Key Investors

Ncoda has successfully secured a significant capital injection, bringing its total funding to $150K. This latest financing round, which accounts for $150K, underscores the organization's pivotal role in the evolving landscape of oncology care. By leveraging this strategic investment, the entity is well-positioned to expand its operational footprint and enhance the delivery of specialized medical services across its network.

The infusion of capital marks a critical milestone in the organization's trajectory, providing the necessary resources to scale its infrastructure and deepen its impact within the oncology sector. As the healthcare industry continues to prioritize integrated care models, this financial backing serves as a testament to the value proposition offered by Ncoda in supporting oncology organizations through complex dispensing challenges.

What is Ncoda?

Ncoda

Organizations

Membership Organizations

The National Community Oncology Dispensing Association (Ncoda) operates as a specialized non-profit organization dedicated to the advancement of medically integrated dispensing (MID) services. By providing a collaborative platform for oncology practices, Ncoda facilitates the operational efficiency required to manage complex medication regimens directly within the clinical setting. This model is essential for improving patient outcomes, ensuring adherence to treatment protocols, and streamlining the pharmacy-to-patient workflow in high-stakes oncology environments. Through its grassroots approach, the organization bridges the gap between clinical expertise and pharmaceutical logistics, establishing itself as a cornerstone of modern oncology infrastructure.

How much funding has Ncoda raised?

Ncoda has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

Key Investors in Ncoda

PPP

Public-Private Partnership

What's next for Ncoda?

With this late-stage funding secured, Ncoda is poised to accelerate its strategic initiatives aimed at standardizing medically integrated dispensing across a broader range of healthcare providers. The organization is expected to focus on enhancing its digital tools and educational resources, which are vital for supporting oncology teams in navigating the complexities of specialty pharmacy management. Furthermore, the capital will likely be deployed to strengthen advocacy efforts and expand the reach of its clinical support programs. By reinforcing its position as a leader in the oncology pharmacy space, Ncoda aims to drive long-term sustainability for its members while ensuring that patients receive seamless, high-quality care throughout their treatment journey.

See full Ncoda company page

See More Financial Insights